OKE vs OVID · P/E 15, rev $21.67B vs rev $733.0K
ONEOK Inc (OKE) versus Ovid Therapeutics Inc (OVID) — a side-by-side from cached financials, not a winner call.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Ovid Therapeutics Inc (OVID) is a biotechnology company listed on US.
Latest reported OKE revenue for 2026-06-30 was $21.67B. Net income was $1.74B. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Latest reported OVID revenue for 2026-06-30 was $733.0K. Net income was -$32.0M. OVID currently screens at market cap $23.5M.
OKE currently screens at market cap $53.92B and trailing P/E 15.3. OVID currently screens at market cap $23.5M.
Not investment advice. Open the OKE and OVID stock pages for the full models.
Not investment advice.